Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Good to see people still hassling them for accustem.
Hilarious response from Tiziana (probably Paul the plumber),
“ All $ACUT
@AccuStem
updates will come from that separately listed company. You can check out their latest S-1 filing from last month on this link”
Basically accustem has nothing do with us ???? what a joke.
If I was on twitter I would ask why they lent okyo and Rasna therapeutics money.
This is the most rotten to the core business I have ever seen. Just such a load of old tripe all the time, probably lifestyle funding and just keep swishing and moving money around until the markets trends upwards then raise and repeat
The way that’s Written with the hashtags etc has Paul the plumber written all over it. I appreciate someone trying to raise profile and boost the SP but I don’t think we need to employ someone to tweet once a fortnight.
Let’s hope the SP only drops a few more % today rather than 10%.
Basically no news.
Tiziana have changed their strap line about 3 times since I’ve been invested.
No major trials, jam tomorrow.
Bought more recently just to try and keep “averaging. Down”.
Wish I had cut my losses and not bought another shilling worth when they dropped. Ridiculously far for them to get back to value and the whole of biotech in a bear market still.
Hope this goes back to like $1.20 and accustem does something mildly decent so I can dump the lot and get out
Fairly sure they have until June/July to regain compliance with the extension. Much as I hate to admit it, they just as well wait than they had recover the SP now with a buy back . Unless they squander the cash I would imagine they have plenty to buy back and keep it above $1 for 10 days or whatever it is. Last time they bought around $800k worth didn’t they IIRC from the accounts/statement?
Anyone have one? We are into the third year now
https://www.tizianalifesciences.com/news-item?s=2020-09-16-tiziana-life-sciences-announces-planned-spin-out-of-stemprinter-into-a-new-publicly-listed-company-accustem-sciences
Unless something substantial changed my mind, I am absolutely uninterested in holding Tiziana or accustem for any other reasons than damage control after “averaging down” as much as I can to get my cash out.
Although some of the tech could be great I have absolutely zero faith now and am more so just hoping for Biotech to rebound so I can dump these and not come back.
I’m not interested in “missing out” on foralumab being a blockbuster or accustem being bought out by exact sciences or such the like. If they can bounce enough to get me out of jail, I am gone. Best of luck to the rest of holders. I totally have no faith left now.
I would love to see full details of the bank accounts and accounts for a day to see exactly where the money is spent. I wonder if there is a lifestyle element to it. Hotels, flights, tech, rental properties etc all paid for by shareholders. I don’t see how they have burnt that much cash for little progress.
Sorry, call me a cynic but you’re probably more likely to win chucking your money on 32 red.
I have topped up plenty here, it’s a complete gamble either it’s a bargain or a total waste of money. Regardless, I won’t be selling out until I see a rerun on this or Tiziana and past that point I will never invest in a company that GC is involved with again.
If this and Tiziana flop then I may make it my life’s work to go on every group and board to ensure others know what they are like!
Correct me if I’m wrong but that’s the equivalent price for “old” accustem shares at price 0.80 dollars for “new” consolidated shares.
Sure beats holding TILS shares @ £1.80 to get the same entitlement!.
1000 current/ new shares will cost around £650 quid
You would have needed around £36,000 in TILS to get that same entitlement at the ex date.
Tiziana announces planned spin-off of Accustem.
Piles available today, not sure why so much all of a sudden. Very tempted to buy some more but just don’t trust anything about any of this any more
Says not a correct price just a guide/example price on the prospectus.
I am reading conflicting information with regards to how long we can expect before listing and the roadshow/pricing etc
Obviously the wheels are thankfully now in motion, surely we can’t be more than a month or two away from listing now?
SP for accustem is back to 0.99 today, that’s less than 4p a “share” for “old” accustem tils entitlements
Each accustem “free” share/ennow would have cost you around £36 in old TILS shares. Means at the current price the “in-specie dividend” is worth around 4p for every tils share you held..
Far cry from the £1 ish valuation that was put on it previously @ $280m.
I wonder how long we have to wait to see what the pricing is on this IPO.
“ The assumed public offering price used throughout this prospectus has been included for illustration purposes only. The actual offering price may differ materially from the assumed price used in the prospectus and will be determined by negotiations between us and the representatives of the underwriters, may not be indicative of prices of the actual offering price.”
I don’t think it’s actually priced yet, that’s just based off recent closed price with a 6/1 reverse split. Maybe it is the case that we 50% dilution but it wood be fairly crap.
So basically all in all at current prices a 120/1 or 60/1 reverse split for tils/Tlsa holders/entitlements.
Surely that can’t be right, 5p an “old” accustem entitlement basically. Hahaha if we have waited 2 years for this I will laugh my taters off
Yeah hang on, isn’t it a 6/1 reverse split and therefore works out around 1.20 a share? Am I missing something here?..
Approx 26 months now for Uk holders?
No update on the ipo, or anything else for that matter.
Kind of wish I sold what I’d acquired when it was available at 1.85 in December.
Perhaps this will just die a slow death as well.
Id love an in depth review on the accounts of both tils and accustem, to see if certain people are just using them as a free credit card for bus class flights across the world etc.
To be fair Wendy blosser etc have actually had a proper job prior to this, but why no update since becoming CEO in March (or whenever it was?) surely can’t be NDA’s or buyouts in place taking this long?
I would love to dump this and tils but massively underwater on the latter.
Broken promises constantly
I think the best course of action is to warn other shareholders constantly both pre and post dumping this.
Can you honestly believe they are slowing operations down (laughable I know) on other products yet loaning millions to companies GC is associated with such as Okyo and Rasna.
I notice they haven’t loaned to other companies that GC doesn’t have an interest in. I remember seeing on LinkedIn Kunwar shailubhai posting something about leaving companies that are engaged in unethical practices (after he left Tiziana) and I wonder if this has something to do with it. That and the fact the auditors resigned.
Rotten to the core, should have taken my fat profit and jumped ship years ago. I have certainly learned a life lesson from this though, don’t believe the proactive interviews and all the other BS where money is involved and they probably couldn’t give a sh*t about shareholders.
Paul the plumber please defend the actions of them somehow here? Honest opinion old chap, don’t you think they have treated shareholders with contempt, regardless of market conditions?
I may have to do the same unless something remarkable comes to light. The lack of comms and direct acknowledgment of the situation has been disheartening to say the least.
You’ve got to be having a laugh? Funnily enough I looked at accustem OTC and it’s only showing 5 million shares or something as being tradeable.
What a balls up of the highest degree, i almost forgot about the debacle of Uk holders being locked into Tiziana shares when they went sole Nasdaq listing. That was a joke that took a lot of time anyway, wasn’t it like 6 months without being able to trade?
Thanks for the reply.
Didn’t they file confidentially in July 2022 though? One would think they are a bit further down the line?
Any clues as to how long we will have to wait now for the next accustem update?
I’ll be honest Bobsson, if I was in your position, I would be contacting someone at Tiziana/accustem and making a complaint to Barclays.
Try get hold of Dr Ted @ Tiziana.
(Shaf. Ted) head of a the investor regret department